Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02804763
Brief Title: A Phase 2 Efficacy and Safety Study of Dapirolizumab Pegol (DZP) in Systemic Lupus Erythematosus

First Submitted : June 14, 2016
First Submitted that Met QC Criteria : June 14, 2016
First Posted : June 17, 2016 (Estimate)

Certification/Extension First Submitted : June 19, 2019
Certification/Extension First Submitted that Met QC Criteria : June 19, 2019
Certification/Extension First Posted : June 21, 2019

Last Update Submitted that Met QC Criteria : July 5, 2019
Last Update Posted : July 9, 2019